Title:
COMPOSITION FOR INHIBITING ERYTHEMA, METHOD OF USING SAME, METHOD FOR PREPARING SAME, METHOD FOR INHIBITING ERYTHEMA, AND LACTIC ACID BACTERIA PRODUCT
Document Type and Number:
WIPO Patent Application WO/2017/164298
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a composition which is used for inhibiting erythema and can sufficiently inhibit skin erythema. This composition for inhibiting erythema includes a polysaccharide-containing lactic acid bacteria product as an active ingredient. It is preferable that the lactic acid bacteria product be produced by a combination of at least one among Lactobacillus delbrueckii subsp. bulgaricus OLL1247 bacteria and Lactobacillus delbrueckii subsp. bulgaricus 2038 bacteria and at least one among Streptococcus thermophilus OLS3078 bacteria and Streptococcus thermophilus 1131 bacteria. It is particularly preferable that this composition for inhibiting erythema further contain at least one among a sphingolipid and a collagen peptide as an active ingredient.
Inventors:
MORIFUJI MASASHI (JP)
ITO KYOKO (JP)
KITADE MASAMI (JP)
FUKASAWA TOMOYUKI (JP)
ITO KYOKO (JP)
KITADE MASAMI (JP)
FUKASAWA TOMOYUKI (JP)
Application Number:
PCT/JP2017/011682
Publication Date:
September 28, 2017
Filing Date:
March 23, 2017
Export Citation:
Assignee:
MEIJI CO LTD (JP)
International Classes:
A61K35/744; A23L33/12; A23L33/125; A23L33/18; A61K31/688; A61K35/20; A61K35/747; A61K38/02; A61P17/16; A61P43/00; C12P19/04
Domestic Patent References:
| WO2016021573A1 | 2016-02-11 | |||
| WO2006095764A1 | 2006-09-14 | |||
| WO2012002322A1 | 2012-01-05 | |||
| WO2015137423A1 | 2015-09-17 | |||
| WO2016111276A1 | 2016-07-14 |
Foreign References:
| JPH0517363A | 1993-01-26 | |||
| JP2008179601A | 2008-08-07 |
Other References:
KAKUHEI IZAWA ET AL.: "Verifying the Ability of Yogurt Prepared with LB81 Lactic Acid Bacteria to Improve Skin Function", JOURNAL OF INTESTINAL MICROBIOLOGY, vol. 22, no. 1, 2008, pages 1 - 5, XP055423140
ARA, K. ET AL.: "Effect of Spore-bearing Lactic Acid-forming Bacteria(Bacillus coagulans SANK 70258) Administration on the Intestinal Environment, Defecation Frequency, Fecal Characteristics and Dermal Characteristics in Humans and Rats", MICROBIAL ECOLOGY IN HEALTH AND DISEASE, vol. 14, no. 1, 2002, pages 4 - 13, XP009158257
MASASHI MORIFUJI ET AL.: "Effect of Fermented Milk Containing SC-2 Lactic Acid Bacteria, Collagen Hydralysates, and Sphingomyelin on Minimal Erythema Dose(MED) in Human Subjects -A Randomized, Placebo-controlled, Double-blind, Parallel-group Stud y", JPN. PHARMACOL. THER., vol. 44, no. 11, 20 November 2016 (2016-11-20), pages 1589 - 1599
MORIFUJI, M. ET AL.: "Exopolysaccharides Isolated from Milk Fermented with Lactic Acid Bcteria Prevent Ultraviolet-Induced Skin Damage in Hairless Mice", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 1, 13 January 2017 (2017-01-13), pages 146, XP055423149
ARA, K. ET AL.: "Effect of Spore-bearing Lactic Acid-forming Bacteria(Bacillus coagulans SANK 70258) Administration on the Intestinal Environment, Defecation Frequency, Fecal Characteristics and Dermal Characteristics in Humans and Rats", MICROBIAL ECOLOGY IN HEALTH AND DISEASE, vol. 14, no. 1, 2002, pages 4 - 13, XP009158257
MASASHI MORIFUJI ET AL.: "Effect of Fermented Milk Containing SC-2 Lactic Acid Bacteria, Collagen Hydralysates, and Sphingomyelin on Minimal Erythema Dose(MED) in Human Subjects -A Randomized, Placebo-controlled, Double-blind, Parallel-group Stud y", JPN. PHARMACOL. THER., vol. 44, no. 11, 20 November 2016 (2016-11-20), pages 1589 - 1599
MORIFUJI, M. ET AL.: "Exopolysaccharides Isolated from Milk Fermented with Lactic Acid Bcteria Prevent Ultraviolet-Induced Skin Damage in Hairless Mice", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 1, 13 January 2017 (2017-01-13), pages 146, XP055423149
Attorney, Agent or Firm:
KITAHARA Hiroyoshi et al. (JP)
Download PDF: